To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Additional recommended knowledge
Pravastatin was identified originally in a bacterium called Nocardia autotrophica by researchers of the Sankyo Pharma Inc. It is presently being marketed outside Japan by the pharmaceutical company Bristol-Myers Squibb.
In 2003, Bristol-Myers Squibb announced in a magazine advertisement that pravastatin is no longer the only statin approved by the FDA proven to reduce the risk of cardiovascular disease, and that rosuvastatin, another statin, is approved to reduce this risk.
The U.S. Food and Drug Administration approved a generic version of Pravastatin for sale in the United States for the first time on April 24, 2006. Generic Pravastatin Sodium Tablets (10mg, 20mg and 40mg) are manufactured by TEVA Pharmaceuticals in Kfar Sava, Israel. FDA Press Release
In 2005, Pravachol was the 22nd highest-selling brand-name drug in the United States. FDA Press Release
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Pravastatin". A list of authors is available in Wikipedia.|